- Report
- April 2024
- 137 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Book
- November 2019
- 440 Pages
- Book
- June 2012
- 252 Pages
United States
- Book
- December 2011
- 492 Pages
- Book
- June 2019
- 336 Pages
Glycosylation is a process in healthcare services that involves the addition of sugar molecules to proteins or lipids. It is a key step in the production of biopharmaceuticals, such as monoclonal antibodies, and is used to improve the stability, solubility, and pharmacokinetics of these drugs. Glycosylation also plays an important role in the development of vaccines and other therapeutic proteins.
The glycosylation market is driven by the increasing demand for biopharmaceuticals and the need for improved drug delivery systems. The market is expected to grow at a steady rate due to the increasing prevalence of chronic diseases, such as cancer and diabetes, and the growing demand for personalized medicine.
Companies in the glycosylation market include GlycoMimetics, Inc., GlycoVaxyn AG, GlycoBioTech, GlycoVax Technologies, GlycoVaxyn, and GlycoVaxyn AG. Show Less Read more